TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 335 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,982 | -12.8% | 3,230,900 | -11.5% | 0.08% | +2.4% |
| Q2 2023 | $57,341 | +17.0% | 3,650,000 | +22.8% | 0.08% | +27.7% |
| Q1 2023 | $49,002 | +9.7% | 2,973,400 | +3.8% | 0.06% | +6.6% |
| Q4 2022 | $44,685 | -99.9% | 2,864,400 | +0.5% | 0.06% | +17.3% |
| Q3 2022 | $36,953,000 | -6.9% | 2,849,100 | +0.7% | 0.05% | +10.6% |
| Q2 2022 | $39,709,000 | +39.1% | 2,828,300 | +41.9% | 0.05% | +42.4% |
| Q1 2022 | $28,543,000 | +21.8% | 1,993,200 | +16.0% | 0.03% | +13.8% |
| Q4 2021 | $23,427,000 | -33.7% | 1,718,800 | -20.3% | 0.03% | -37.0% |
| Q3 2021 | $35,330,000 | -8.6% | 2,156,900 | -6.1% | 0.05% | -4.2% |
| Q2 2021 | $38,659,000 | -38.4% | 2,297,000 | -33.1% | 0.05% | -38.5% |
| Q1 2021 | $62,716,000 | -38.2% | 3,434,600 | -38.4% | 0.08% | -29.1% |
| Q4 2020 | $101,532,000 | -0.8% | 5,578,700 | -2.8% | 0.11% | +7.8% |
| Q3 2020 | $102,343,000 | +1.8% | 5,736,707 | +2.3% | 0.10% | +17.2% |
| Q2 2020 | $100,546,000 | +76.0% | 5,607,700 | +49.0% | 0.09% | +58.2% |
| Q1 2020 | $57,128,000 | +44.2% | 3,763,400 | +87.4% | 0.06% | +83.3% |
| Q4 2019 | $39,622,000 | +35.2% | 2,008,189 | +17.8% | 0.03% | +20.0% |
| Q3 2019 | $29,316,000 | +114.0% | 1,704,400 | +120.3% | 0.02% | +108.3% |
| Q2 2019 | $13,696,000 | – | 773,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |